Empowered Patient Podcast

Dr. Barbara Klencke, Chief Development Officer, Sierra Oncology talks about the development of momelotinib for myelofibrosis, a rare blood cancer. Momelotinib's unique mechanism of action allows it to address all three key symptoms of myelofibrosis, including the debilitating anemia which can be exacerbated by currently available therapies. The Phase 3 MOMENTUM Clinical Trial evaluating momelotinib for patients with MF is currently recruiting globally. To learn more: momentumtrial.com

#myelofibrosis #JAKInhibitor #ClinicalTrial #RareCancer

SierraOncology.com

Listen to the podcast here

Dr. Barbara Klencke, Chief Development Officer, Sierra Oncology talks about the development of momelotinib for myelofibrosis, a rare blood cancer. Momelotinib's unique mechanism of action allows it to address all three key symptoms of myelofibrosis, including the debilitating anemia which can be exacerbated by currently available therapies. The Phase 3 MOMENTUM Clinical Trial evaluating momelotinib for patients with MF is currently recruiting globally. To learn more: momentumtrial.com

#myelofibrosis #JAKInhibitor #ClinicalTrial #RareCancer

SierraOncology.com

Download the transcript here

Robert Ferguson, nutritionist, author, Health Ambassador to StayHealthy, and creator of DietFreeLife talks about the risk factors and pre-existing health inequalities in the African American community that have led to a high rate of infection from COVID-19. Robert is particularly focused on excess body fat and the impact of what we eat on diabetes, cancer and hypertension. He emphasizes the need to be more health conscious and to resist peer pressure, questionable sources of health information and diet fads.

@dietfreelife #COVID19 #StayHealthy #dietfreelife

DietFreeLife.com

Listen to the podcast here

Robert Ferguson, nutritionist, author, Health Ambassador to StayHealthy, and creator of DietFreeLife talks about the risk factors and pre-existing health inequalities in the African American community that have led to a high rate of infection from COVID-19. Robert is particularly focused on excess body fat and the impact of what we eat on diabetes, cancer and hypertension. He emphasizes the need to be more health conscious and to resist peer pressure, questionable sources of health information and diet fads.

@dietfreelife #COVID19 #StayHealthy #dietfreelife

DietFreeLife.com

Download the transcript here

Andreas Boeckl, founder, Dispersa Labs is bringing to the market Sula, breathable cannabis, which is inhaled from measured doses using a device that does not require combustion. This approach to dosing medical cannabis for specific conditions like neurological disorders, stress, anxiety, PTSD, and pain provides much faster relief than edible cannabis and allows for more flexibility for where the cannabis can be administered. Andreas also emphasizes the value of this solution for researchers who are studying the use of cannabinoids.

@breathesula #cannabis #Sula #cannabinoids #PTSD

Breathesula.com

Listen to the podcast here

Andreas Boeckl, founder, Dispersa Labs is bringing to the market Sula, breathable cannabis, which is inhaled from measured doses using a device that does not require combustion. This approach to dosing medical cannabis for specific conditions like neurological disorders, stress, anxiety, PTSD, and pain provides much faster relief than edible cannabis and allows for more flexibility for where the cannabis can be administered. Andreas also emphasizes the value of this solution for researchers who are studying the use of cannabinoids.

@breathesula #cannabis #BreatheSula #PTSD #cannabinoids

Breathesula.com

Download the transcript here

Laurent Levy, CEO, Nanobiotix talks about using nanoparticles and nanotechnology to destroy cancer cells by bringing a physics perspective to drug development. The Nanobiotix technology has demonstrated improvement in the efficacy of radiation therapy for patients with soft tissue sarcoma, with an intention to expand across oncology, reducing the side effects and potentially reducing duration of the radiation.

#nanobiotix #nanomedicine #cancer #radiationtherapy

Nanobiotix.com

Listen to the podcast here

Laurent Levy, CEO, Nanobiotix talks about using nanoparticles and nanotechnology to destroy cancer cells by bringing a physics perspective to drug development. The Nanobiotix technology has demonstrated improvement in the efficacy of radiation therapy for patients with soft tissue sarcoma, with an intention to expand across oncology, reducing the side effects and potentially reducing duration of the radiation.

#nanobiotix #nanomedicine #cancer #radiationtherapy

Nanobiotix.com

Download the transcript here

Nancy Hornberger, EVP, ElectrifAi, worked with IBM and the Watson Group earlier in her career. She brings expertise about data and the health care industry to a company that is using advanced machine learning and artificial intelligence to drive profit improvement, increase performance and reduce risk. We talk about the role of ML and Ai in helping to balance system demands by managing healthcare providers and staff and streamlining processes by reducing the mundane work of looking at raw data and images so that clinicians can make better and faster diagnostic decisions.

@ElectrifAi #Ai #ML #COVID19

ElectrifAi.net

Listen to the podcast here

Nancy Hornberger, EVP, ElectrifAi, worked with IBM and the Watson Group earlier in her career. She brings expertise about data and the health care industry to a company that is using advanced machine learning and artificial intelligence to drive profit improvement, increase performance and reduce risk. We talk about the role of ML and Ai in helping to balance system demands by managing healthcare providers and staff and streamlining processes by reducing the mundane work of looking at raw data and images so that clinicians can make better and faster diagnostic decisions.

@ElectrifAi #Ai #ML #COVID19

ElectrifAi.net

Download the transcript here